Neuronal Antibodies in Patients With Atypical Parkinsonism
Routine testing for anti-IgLON5 or other neuronal antibodies in AP is not recommended, but careful clinical phenotyping is essential to uncover additional features that might suggest an underlying antibody-associated disease in selected patient cases.